Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Quinn

Showing results (41-50 of 195) with videos related to

Pageof 20
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1994
Are Lewy bodies non-specific epiphenomena of nigral damage?G Wenning, N Quinn
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Parkinsonism following electrical injury to the handN Quinn, D Maraganore
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1984
A double blind trial of sulpiride in Huntington's disease and tardive dyskinesiaN Quinn, C D Marsden
Nursing Outlook|April 1, 1974
The Patient's Bill of Rights: a significant aspect of the consumer revolutionN Quinn, A R Somers
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1985
Tiapride in 12 Huntington's disease patientsN Quinn, C D Marsden
Lancet (London, England)|June 14, 1986
Lithium for painful dystonia in Parkinson's diseaseN Quinn, C D Marsden
International Journal of Drug Discovery and Pharmacology|July 16, 2025
Hippo Signaling: Advances in Potential Therapeutic Targets for Sinoatrial Node DisordersJulianna N Quinn, Jun Wang
Journal of Neurology, Neurosurgery, and Psychiatry|August 17, 2000
What contributes to quality of life in patients with Parkinson's disease?A Schrag, M Jahanshahi, N Quinn
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
How does Parkinson's disease affect quality of life? A comparison with quality of life in the general populationA Schrag, M Jahanshahi, N Quinn
Revue Neurologique|January 1, 1981
[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)]Y Agid, N Quinn, F Lhermitte
Pageof 20

Showing results (41-50 of 195) with videos related to

Sort By:
Pageof 20
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1994
Are Lewy bodies non-specific epiphenomena of nigral damage?G Wenning, N Quinn
Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2000
Parkinsonism following electrical injury to the handN Quinn, D Maraganore
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1984
A double blind trial of sulpiride in Huntington's disease and tardive dyskinesiaN Quinn, C D Marsden
Nursing Outlook|April 1, 1974
The Patient's Bill of Rights: a significant aspect of the consumer revolutionN Quinn, A R Somers
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1985
Tiapride in 12 Huntington's disease patientsN Quinn, C D Marsden
Lancet (London, England)|June 14, 1986
Lithium for painful dystonia in Parkinson's diseaseN Quinn, C D Marsden
International Journal of Drug Discovery and Pharmacology|July 16, 2025
Hippo Signaling: Advances in Potential Therapeutic Targets for Sinoatrial Node DisordersJulianna N Quinn, Jun Wang
Journal of Neurology, Neurosurgery, and Psychiatry|August 17, 2000
What contributes to quality of life in patients with Parkinson's disease?A Schrag, M Jahanshahi, N Quinn
Movement Disorders : Official Journal of the Movement Disorder Society|December 5, 2000
How does Parkinson's disease affect quality of life? A comparison with quality of life in the general populationA Schrag, M Jahanshahi, N Quinn
Revue Neurologique|January 1, 1981
[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)]Y Agid, N Quinn, F Lhermitte
Pageof 20